SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-22-156129
Filing Date
2022-05-20
Accepted
2022-05-20 16:06:45
Documents
9
Effectiveness Date
2022-05-20

Document Format Files

Seq Description Document Type Size
1 S-8 d265791ds8.htm S-8 59943
2 EX-5.1 d265791dex51.htm EX-5.1 8208
3 EX-23.1 d265791dex231.htm EX-23.1 1695
4 EX-99.1 d265791dex991.htm EX-99.1 86094
5 EX-99.2 d265791dex992.htm EX-99.2 69093
6 EX-99.3 d265791dex993.htm EX-99.3 49937
7 EX-99.4 d265791dex994.htm EX-99.4 84888
8 EX-FILING FEES d265791dexfilingfees.htm EX-FILING FEES 22663
9 GRAPHIC g265791g0518015247823.jpg GRAPHIC 2533
  Complete submission text file 0001193125-22-156129.txt   387170
Mailing Address 269 EAST GRAND AVE SOUTH SAN FRANCISCO CA 94080
Business Address 269 EAST GRAND AVE SOUTH SAN FRANCISCO CA 94080 415-910-5717
Cortexyme, Inc. (Filer) CIK: 0001662774 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-265109 | Film No.: 22947613
SIC: 2836 Biological Products, (No Diagnostic Substances)